Fecal Microbiota Signatures Are Not Consistently Related to Symptom Severity in Irritable Bowel Syndrome

[1] Canavan C(2014)The epidemiology of irritable bowel syndrome Clin Epidemiol 6 71-958

[2] West J(2015)Irritable bowel syndrome: a clinical review JAMA 313 949-1290

[3] Card T(2012)The brain–gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study Gut 61 1284-389

[4] Chey WD(2005)Visceral sensitivity and symptoms in patients with constipation-or diarrhea-predominant irritable bowel syndrome (IBS): effect of a low-fat intraduodenal infusion Am J Gastroenterol 100 383-2578

[5] Kurlander J(2017)Irritable bowel syndrome N Engl J Med 376 2566-1801

[6] Eswaran S(2011)Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome Gastroenterology 141 1792-108

[7] Koloski NA(2019)Gut microbiota in patients with irritable bowel syndrome—a systematic review Gastroenterology 157 97-10

[8] Jones M(2020)Individual and cohort-specific gut microbiota patterns associated with tissue-specific insulin sensitivity in overweight and obese males Sci Rep 10 1-222

[9] Kalantar J(2005)Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome—a longitudinal study in IBS and control subjects FEMS Immunol Med Microbiol 43 213-633

[10] Caldarella MP(2006)Prevalence and temporal stability of selected clostridial groups in irritable bowel syndrome in relation to predominant faecal bacteria J Med Microbiol 55 625-41

[1] Canavan C(2014)The epidemiology of irritable bowel syndrome Clin Epidemiol 6 71-958

[2] West J(2015)Irritable bowel syndrome: a clinical review JAMA 313 949-1290

[3] Card T(2012)The brain–gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study Gut 61 1284-389

[4] Chey WD(2005)Visceral sensitivity and symptoms in patients with constipation-or diarrhea-predominant irritable bowel syndrome (IBS): effect of a low-fat intraduodenal infusion Am J Gastroenterol 100 383-2578

[5] Kurlander J(2017)Irritable bowel syndrome N Engl J Med 376 2566-1801

[6] Eswaran S(2011)Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome Gastroenterology 141 1792-108

[7] Koloski NA(2019)Gut microbiota in patients with irritable bowel syndrome—a systematic review Gastroenterology 157 97-10

[8] Jones M(2020)Individual and cohort-specific gut microbiota patterns associated with tissue-specific insulin sensitivity in overweight and obese males Sci Rep 10 1-222

[9] Kalantar J(2005)Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome—a longitudinal study in IBS and control subjects FEMS Immunol Med Microbiol 43 213-633

[10] Caldarella MP(2006)Prevalence and temporal stability of selected clostridial groups in irritable bowel syndrome in relation to predominant faecal bacteria J Med Microbiol 55 625-41